ClinicalTrials.govpublic full text
Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
hematopoietic/lymphoid cancer, acute myeloid leukemia, aml, relapsed or refractory cd33-positive, cd33-car-t cells, fludarabine, fludarabine phosphate, fludara, cyclophosphamide, cytoxan, neosar, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 801882
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.